speb/financial-data huggingface dataset:
CD.V income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
CD.V income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
CD.V balance_sheet (quarterly, 2026-01-31) — Taxes Receivable: 22203.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Assets: 2761089.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 1473995.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Debt: 0.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: 1473995.00
CD.V income_statement (quarterly, 2026-01-31) — Total Expenses: 443139.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1287094.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 486867.00
CD.V balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 604000.00
CD.V income_statement (quarterly, 2026-01-31) — Total Unusual Items: -1659.00
CD.V income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: -1659.00
CD.V balance_sheet (quarterly, 2026-01-31) — Working Capital: 1591128.00
CD.V income_statement (quarterly, 2026-04-30) — +Operating Expense: 497158.00
CD.V income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Accounts Payable: 181089.00
CD.V balance_sheet (quarterly, 2026-04-30) — Accumulated Depreciation: -304555.00
CD.V income_statement (quarterly, 2026-04-30) — Basic Average Shares: 158968217.00
CD.V income_statement (quarterly, 2026-04-30) — Basic EPS: -0.01
CD.V cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 2157440.00
CD.V balance_sheet (quarterly, 2026-04-30) — Capital Lease Obligations: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Capital Stock: 99847167.00
CD.V balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 1654529.00
CD.V balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 1654529.00
CD.V balance_sheet (quarterly, 2026-04-30) — Cash Financial: 1654529.00
CD.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 84000.00
CD.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: 0.00
CD.V cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -586911.00
CD.V cash_flow (quarterly, 2026-04-30) — Change In Payable: -21505.00
CD.V cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: -21505.00
CD.V cash_flow (quarterly, 2026-04-30) — Change In Receivables: -125318.00
CD.V cash_flow (quarterly, 2026-04-30) — Change In Working Capital: -146823.00
CD.V cash_flow (quarterly, 2026-04-30) — Changes In Cash: -502911.00
CD.V balance_sheet (quarterly, 2026-04-30) — Common Stock: 99847167.00
CD.V balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 1167017.00
CD.V cash_flow (quarterly, 2026-04-30) — Common Stock Issuance: 84000.00
CD.V income_statement (quarterly, 2026-04-30) — Cost Of Revenue: 754.00
CD.V balance_sheet (quarterly, 2026-04-30) — Current Assets: 1896629.00
CD.V balance_sheet (quarterly, 2026-04-30) — Current Capital Lease Obligation: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 598589.00
CD.V cash_flow (quarterly, 2026-04-30) — Depreciation: 754.00
CD.V cash_flow (quarterly, 2026-04-30) — Depreciation Amortization Depletion: 754.00
CD.V cash_flow (quarterly, 2026-04-30) — Depreciation And Amortization: 754.00
CD.V income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 158968217.00
CD.V income_statement (quarterly, 2026-04-30) — Diluted EPS: -0.01
CD.V income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: -418148.00
CD.V balance_sheet (quarterly, 2026-04-30) — Dueto Related Parties Current: 125800.00
CD.V income_statement (quarterly, 2026-04-30) — EBIT: -497912.00
CD.V income_statement (quarterly, 2026-04-30) — EBITDA: -497158.00
CD.V cash_flow (quarterly, 2026-04-30) — End Cash Position: 1654529.00
CD.V cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 84000.00
CD.V cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -586911.00
CD.V income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 3955.00
CD.V balance_sheet (quarterly, 2026-04-30) — Gains Losses Not Affecting Retained Earnings: 1177205.00
CD.V income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 74827.00
CD.V balance_sheet (quarterly, 2026-04-30) — Gross PPE: 719198.00
CD.V income_statement (quarterly, 2026-04-30) — Gross Profit: -754.00
CD.V cash_flow (quarterly, 2026-04-30) — Income Tax Paid Supplemental Data: 0.00
CD.V income_statement (quarterly, 2026-04-30) — Interest Income: 12809.00
CD.V income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 12809.00
CD.V cash_flow (quarterly, 2026-04-30) — Interest Paid Supplemental Data: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Invested Capital: 1167017.00
CD.V cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: 0.00
CD.V cash_flow (quarterly, 2026-04-30) — Issuance Of Capital Stock: 84000.00
CD.V balance_sheet (quarterly, 2026-04-30) — Long Term Provisions: 604000.00
CD.V balance_sheet (quarterly, 2026-04-30) — Machinery Furniture Equipment: 10982.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Common Stock Issuance: 84000.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Foreign Currency Exchange Gain Loss: -266.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: -418148.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: -418148.00
CD.V income_statement (quarterly, 2026-04-30) — Net Interest Income: 12809.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: 0.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Long Term Debt Issuance: 0.00
CD.V income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: 12809.00
CD.V cash_flow (quarterly, 2026-04-30) — Net Other Financing Charges: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Net PPE: 414643.00
CD.V cash_flow (quarterly, 2026-04-30) — Net PPE Purchase And Sale: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 1167017.00
CD.V income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -501113.00
CD.V income_statement (quarterly, 2026-04-30) — Normalized Income: -422103.00
CD.V cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -586911.00
CD.V cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -266.00
CD.V income_statement (quarterly, 2026-04-30) — Operating Income: -497912.00
CD.V income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 159226082.00
CD.V balance_sheet (quarterly, 2026-04-30) — Other Current Liabilities: 291700.00
CD.V balance_sheet (quarterly, 2026-04-30) — Other Equity Adjustments: 1177205.00
CD.V income_statement (quarterly, 2026-04-30) — Other Gand A: 47657.00
CD.V income_statement (quarterly, 2026-04-30) — Other Income Expense: 66955.00
CD.V cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: -49598.00
CD.V balance_sheet (quarterly, 2026-04-30) — Other Non Current Assets: 58334.00
CD.V income_statement (quarterly, 2026-04-30) — Other Non Operating Income Expenses: 63000.00
CD.V income_statement (quarterly, 2026-04-30) — Other Operating Expenses: 422331.00
CD.V balance_sheet (quarterly, 2026-04-30) — Other Properties: 708216.00
CD.V balance_sheet (quarterly, 2026-04-30) — Payables: 306889.00
CD.V balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 306889.00
CD.V balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 222952.00
CD.V income_statement (quarterly, 2026-04-30) — Pretax Income: -418148.00
CD.V cash_flow (quarterly, 2026-04-30) — Purchase Of PPE: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Receivables: 19148.00
CD.V income_statement (quarterly, 2026-04-30) — Reconciled Cost Of Revenue: 754.00
CD.V income_statement (quarterly, 2026-04-30) — Reconciled Depreciation: 754.00
CD.V balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -99857355.00
CD.V income_statement (quarterly, 2026-04-30) — Salaries And Wages: 27170.00
CD.V income_statement (quarterly, 2026-04-30) — Selling General And Administration: 74827.00
CD.V balance_sheet (quarterly, 2026-04-30) — Share Issued: 159226082.00
CD.V cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: 27170.00
CD.V balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 1167017.00
CD.V balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 1167017.00
CD.V income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 0.00
CD.V income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Taxes Receivable: 19148.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Assets: 2369606.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 1167017.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Debt: 0.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 1167017.00
CD.V income_statement (quarterly, 2026-04-30) — Total Expenses: 497912.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 1202589.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 472977.00
CD.V balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 604000.00
CD.V income_statement (quarterly, 2026-04-30) — Total Unusual Items: 3955.00
CD.V income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 3955.00
CD.V balance_sheet (quarterly, 2026-04-30) — Working Capital: 1298040.00
CD1.AX income_statement (annual, 2022-03-31) — +Total Revenue: -197952.00
CD1.AX balance_sheet (annual, 2022-03-31) — Accounts Payable: 117831.00
CD1.AX balance_sheet (annual, 2022-03-31) — Accounts Receivable: 10569.00
CD1.AX income_statement (annual, 2022-03-31) — Basic Average Shares: 38401886.00
CD1.AX income_statement (annual, 2022-03-31) — Basic EPS: 0.29
CD1.AX cash_flow (annual, 2022-03-31) — Beginning Cash Position: 3365832.00
CD1.AX balance_sheet (annual, 2022-03-31) — Capital Stock: 57651733.00
CD1.AX balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 5375159.00
CD1.AX balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 5375159.00
CD1.AX cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -24519460.00
CD1.AX balance_sheet (annual, 2022-03-31) — Cash Financial: 5375159.00
CD1.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: -26730371.00
CD1.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: 29457311.00
CD1.AX cash_flow (annual, 2022-03-31) — Cash Flowsfromusedin Operating Activities Direct: -706053.00
CD1.AX cash_flow (annual, 2022-03-31) — Changes In Cash: 2020887.00
CD1.AX cash_flow (annual, 2022-03-31) — Classesof Cash Payments: -713013.00
CD1.AX cash_flow (annual, 2022-03-31) — Classesof Cash Receiptsfrom Operating Activities: 6960.00
CD1.AX balance_sheet (annual, 2022-03-31) — Common Stock: 57651733.00
CD1.AX cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -24519460.00
CD1.AX balance_sheet (annual, 2022-03-31) — Common Stock Equity: 49920618.00
CD1.AX cash_flow (annual, 2022-03-31) — Common Stock Payments: -2210911.00
CD1.AX balance_sheet (annual, 2022-03-31) — Current Deferred Liabilities: 66504.00
CD1.AX balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 66504.00
CD1.AX income_statement (annual, 2022-03-31) — Diluted Average Shares: 38401886.00
CD1.AX income_statement (annual, 2022-03-31) — Diluted EPS: 0.29
CD1.AX cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 29457311.00
CD1.AX cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: -11560.00
CD1.AX cash_flow (annual, 2022-03-31) — End Cash Position: 5375159.00
CD1.AX cash_flow (annual, 2022-03-31) — Financing Cash Flow: -26730371.00
CD1.AX cash_flow (annual, 2022-03-31) — Free Cash Flow: -706053.00
CD1.AX balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 10569.00
CD1.AX cash_flow (annual, 2022-03-31) — Income Tax Paid Supplemental Data: 58101.00
CD1.AX income_statement (annual, 2022-03-31) — Interest Income: 6867.00
CD1.AX cash_flow (annual, 2022-03-31) — Investing Cash Flow: 29457311.00
CD1.AX balance_sheet (annual, 2022-03-31) — Investments And Advances: 46297572.00
CD1.AX balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 46297572.00
CD1.AX cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -2210911.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Net Interest Income: 6867.00
CD1.AX balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 49920618.00
CD1.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 1587540.00
CD1.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1587540.00
CD1.AX income_statement (annual, 2022-03-31) — Normalized Income: 11326594.00
CD1.AX income_statement (annual, 2022-03-31) — Operating Revenue: -197952.00
CD1.AX balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 37197082.00
CD1.AX income_statement (annual, 2022-03-31) — Other Non Interest Expense: 7278.00
CD1.AX income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 13171060.00
CD1.AX balance_sheet (annual, 2022-03-31) — Payables: 117831.00
CD1.AX balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 117831.00
CD1.AX income_statement (annual, 2022-03-31) — Pretax Income: 12483341.00
CD1.AX income_statement (annual, 2022-03-31) — Professional Expense And Contract Services Expense: 482489.00
CD1.AX balance_sheet (annual, 2022-03-31) — Receivables: 10569.00
CD1.AX cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -2210911.00
CD1.AX balance_sheet (annual, 2022-03-31) — Retained Earnings: -7731115.00
CD1.AX balance_sheet (annual, 2022-03-31) — Share Issued: 37197082.00
CD1.AX balance_sheet (annual, 2022-03-31) — Stockholders Equity: 49920618.00
CD1.AX balance_sheet (annual, 2022-03-31) — Tangible Book Value: 49920618.00
CD1.AX income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CD1.AX income_statement (annual, 2022-03-31) — Tax Provision: 1156747.00
CD1.AX income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.09
CD1.AX balance_sheet (annual, 2022-03-31) — Total Assets: 51692493.00
CD1.AX balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 49920618.00
CD1.AX balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 1771875.00
CD1.AX income_statement (annual, 2023-03-31) — +Total Revenue: -143653.00
CD1.AX balance_sheet (annual, 2023-03-31) — Accounts Payable: 172446.00
CD1.AX balance_sheet (annual, 2023-03-31) — Accounts Receivable: 14088.00
CD1.AX income_statement (annual, 2023-03-31) — Basic Average Shares: 36628796.00
CD1.AX income_statement (annual, 2023-03-31) — Basic EPS: 0.03
CD1.AX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 5375159.00
CD1.AX balance_sheet (annual, 2023-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 3611323.00
CD1.AX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 3611323.00
CD1.AX cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -8041259.00
CD1.AX balance_sheet (annual, 2023-03-31) — Cash Financial: 3611323.00
CD1.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: -8743427.00
CD1.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: 7591393.00
CD1.AX cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: -667779.00
CD1.AX cash_flow (annual, 2023-03-31) — Changes In Cash: -1819813.00
CD1.AX cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -746143.00
CD1.AX cash_flow (annual, 2023-03-31) — Classesof Cash Receiptsfrom Operating Activities: 78364.00
CD1.AX balance_sheet (annual, 2023-03-31) — Common Stock: 56949566.00
CD1.AX cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -8041259.00
CD1.AX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 42290849.00
CD1.AX cash_flow (annual, 2023-03-31) — Common Stock Payments: -702168.00
CD1.AX income_statement (annual, 2023-03-31) — Diluted Average Shares: 36628796.00
CD1.AX income_statement (annual, 2023-03-31) — Diluted EPS: 0.03
CD1.AX cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 7591393.00
CD1.AX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 55977.00
CD1.AX cash_flow (annual, 2023-03-31) — End Cash Position: 3611323.00
CD1.AX cash_flow (annual, 2023-03-31) — Financing Cash Flow: -8743427.00
CD1.AX cash_flow (annual, 2023-03-31) — Free Cash Flow: -667779.00
CD1.AX balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 14088.00
CD1.AX cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 136.00
CD1.AX income_statement (annual, 2023-03-31) — Interest Income: 84870.00
CD1.AX cash_flow (annual, 2023-03-31) — Investing Cash Flow: 7591393.00
CD1.AX balance_sheet (annual, 2023-03-31) — Investments And Advances: 39169590.00
CD1.AX balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 39169590.00
CD1.AX cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -702168.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Net Interest Income: 84870.00
CD1.AX balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 42290849.00
CD1.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 1104346.00
CD1.AX balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1104346.00
CD1.AX income_statement (annual, 2023-03-31) — Normalized Income: 1113657.00
CD1.AX income_statement (annual, 2023-03-31) — Operating Revenue: -143653.00
CD1.AX balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX income_statement (annual, 2023-03-31) — Other Non Interest Expense: 160755.00
CD1.AX income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 496453.00
CD1.AX balance_sheet (annual, 2023-03-31) — Payables: 172446.00
CD1.AX balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 172446.00
CD1.AX income_statement (annual, 2023-03-31) — Pretax Income: -381719.00
CD1.AX income_statement (annual, 2023-03-31) — Professional Expense And Contract Services Expense: 573764.00
CD1.AX balance_sheet (annual, 2023-03-31) — Receivables: 14088.00
CD1.AX cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -702168.00
CD1.AX balance_sheet (annual, 2023-03-31) — Retained Earnings: -14658717.00
CD1.AX balance_sheet (annual, 2023-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (annual, 2023-03-31) — Stockholders Equity: 42290849.00
CD1.AX balance_sheet (annual, 2023-03-31) — Tangible Book Value: 42290849.00
CD1.AX income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
CD1.AX income_statement (annual, 2023-03-31) — Tax Provision: -1495376.00
CD1.AX income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
CD1.AX balance_sheet (annual, 2023-03-31) — Total Assets: 43567641.00
CD1.AX balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 42290849.00
CD1.AX balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1276792.00
CD1.AX income_statement (annual, 2024-03-31) — +Total Revenue: 110560.00
CD1.AX balance_sheet (annual, 2024-03-31) — Accounts Payable: 189108.00
CD1.AX balance_sheet (annual, 2024-03-31) — Accounts Receivable: 12653.00
CD1.AX income_statement (annual, 2024-03-31) — Basic Average Shares: 36551180.00
CD1.AX income_statement (annual, 2024-03-31) — Basic EPS: 0.04
CD1.AX cash_flow (annual, 2024-03-31) — Beginning Cash Position: 3611323.00
CD1.AX balance_sheet (annual, 2024-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3142301.00
CD1.AX balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 3142301.00
CD1.AX cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -5848189.00
CD1.AX balance_sheet (annual, 2024-03-31) — Cash Financial: 3142301.00
CD1.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -5848189.00
CD1.AX cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: 5835735.00
CD1.AX cash_flow (annual, 2024-03-31) — Cash Flowsfromusedin Operating Activities Direct: -527904.00
CD1.AX cash_flow (annual, 2024-03-31) — Changes In Cash: -540358.00
CD1.AX cash_flow (annual, 2024-03-31) — Classesof Cash Payments: -618252.00
CD1.AX cash_flow (annual, 2024-03-31) — Classesof Cash Receiptsfrom Operating Activities: 90348.00
CD1.AX balance_sheet (annual, 2024-03-31) — Common Stock: 56949566.00
CD1.AX cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -5848189.00
CD1.AX balance_sheet (annual, 2024-03-31) — Common Stock Equity: 37727087.00
CD1.AX income_statement (annual, 2024-03-31) — Diluted Average Shares: 36551180.00
CD1.AX income_statement (annual, 2024-03-31) — Diluted EPS: 0.04
CD1.AX cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 5835735.00
CD1.AX cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 71336.00
CD1.AX cash_flow (annual, 2024-03-31) — End Cash Position: 3142301.00
CD1.AX cash_flow (annual, 2024-03-31) — Financing Cash Flow: -5848189.00
CD1.AX cash_flow (annual, 2024-03-31) — Free Cash Flow: -527904.00
CD1.AX balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 12653.00
CD1.AX income_statement (annual, 2024-03-31) — Interest Income: 89499.00
CD1.AX cash_flow (annual, 2024-03-31) — Investing Cash Flow: 5835735.00
CD1.AX balance_sheet (annual, 2024-03-31) — Investments And Advances: 34629959.00
CD1.AX balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 34629959.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Net Interest Income: 89499.00
CD1.AX balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 37727087.00
CD1.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 751521.00
CD1.AX balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 751521.00
CD1.AX income_statement (annual, 2024-03-31) — Normalized Income: 1284427.00
CD1.AX income_statement (annual, 2024-03-31) — Operating Revenue: 110560.00
CD1.AX balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX income_statement (annual, 2024-03-31) — Other Non Interest Expense: 23944.00
CD1.AX income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 1259343.00
CD1.AX balance_sheet (annual, 2024-03-31) — Payables: 189108.00
CD1.AX balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 189108.00
CD1.AX income_statement (annual, 2024-03-31) — Pretax Income: 807964.00
CD1.AX income_statement (annual, 2024-03-31) — Professional Expense And Contract Services Expense: 537995.00
CD1.AX balance_sheet (annual, 2024-03-31) — Receivables: 12653.00
CD1.AX balance_sheet (annual, 2024-03-31) — Retained Earnings: -19222479.00
CD1.AX balance_sheet (annual, 2024-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (annual, 2024-03-31) — Stockholders Equity: 37727087.00
CD1.AX balance_sheet (annual, 2024-03-31) — Tangible Book Value: 37727087.00
CD1.AX income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CD1.AX income_statement (annual, 2024-03-31) — Tax Provision: -476463.00
CD1.AX income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
CD1.AX balance_sheet (annual, 2024-03-31) — Total Assets: 38667716.00
CD1.AX balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 37727087.00
CD1.AX balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 940629.00
CD1.AX income_statement (annual, 2025-03-31) — +Total Revenue: 60149.00
CD1.AX balance_sheet (annual, 2025-03-31) — Accounts Payable: 113448.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 113448.00
CD1.AX balance_sheet (annual, 2025-03-31) — Accounts Receivable: 8955.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 8955.00
CD1.AX income_statement (annual, 2025-03-31) — Basic Average Shares: 36551180.00
CD1.AX income_statement (annual, 2025-03-31) — Basic EPS: 0.02
CD1.AX cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3142301.00
CD1.AX balance_sheet (annual, 2025-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1816686.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1816686.00
CD1.AX balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1816686.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1816686.00
CD1.AX cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -4934409.00
CD1.AX balance_sheet (annual, 2025-03-31) — Cash Financial: 1816686.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1816686.00
CD1.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4934409.00
CD1.AX cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: 4089535.00
CD1.AX cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: -520227.00
CD1.AX cash_flow (annual, 2025-03-31) — Changes In Cash: -1365101.00
CD1.AX cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -580991.00
CD1.AX cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 60764.00
CD1.AX balance_sheet (annual, 2025-03-31) — Common Stock: 56949566.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Common Stock: 56949566.00
CD1.AX cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -4934409.00
CD1.AX balance_sheet (annual, 2025-03-31) — Common Stock Equity: 33523406.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 33523406.00
CD1.AX income_statement (annual, 2025-03-31) — Diluted Average Shares: 36551180.00
CD1.AX income_statement (annual, 2025-03-31) — Diluted EPS: 0.02
CD1.AX cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 4089535.00
CD1.AX cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 39486.00
CD1.AX cash_flow (annual, 2025-03-31) — End Cash Position: 1816686.00
CD1.AX cash_flow (annual, 2025-03-31) — Financing Cash Flow: -4934409.00
CD1.AX cash_flow (annual, 2025-03-31) — Free Cash Flow: -520227.00
CD1.AX balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 8955.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 8955.00
CD1.AX income_statement (annual, 2025-03-31) — Interest Income: 57649.00
CD1.AX cash_flow (annual, 2025-03-31) — Investing Cash Flow: 4089535.00
CD1.AX balance_sheet (annual, 2025-03-31) — Investments And Advances: 31423844.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 31423844.00
CD1.AX balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 31423844.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 31423844.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Net Interest Income: 57649.00
CD1.AX balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 33523406.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 33523406.00
CD1.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Liabilities: 519566.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 519566.00
CD1.AX balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 519566.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 519566.00
CD1.AX income_statement (annual, 2025-03-31) — Normalized Income: 730728.00
CD1.AX income_statement (annual, 2025-03-31) — Operating Revenue: 60149.00
CD1.AX balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX income_statement (annual, 2025-03-31) — Other Non Interest Expense: 5067.00
CD1.AX income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 876272.00
CD1.AX balance_sheet (annual, 2025-03-31) — Payables: 113448.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Payables: 113448.00
CD1.AX balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 113448.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 113448.00
CD1.AX income_statement (annual, 2025-03-31) — Pretax Income: 494581.00
CD1.AX income_statement (annual, 2025-03-31) — Professional Expense And Contract Services Expense: 436773.00
CD1.AX balance_sheet (annual, 2025-03-31) — Receivables: 8955.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Receivables: 8955.00
CD1.AX balance_sheet (annual, 2025-03-31) — Retained Earnings: -23426160.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -23426160.00
CD1.AX balance_sheet (annual, 2025-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (annual, 2025-03-31) — Stockholders Equity: 33523406.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 33523406.00
CD1.AX balance_sheet (annual, 2025-03-31) — Tangible Book Value: 33523406.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 33523406.00
CD1.AX income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CD1.AX income_statement (annual, 2025-03-31) — Tax Provision: -236147.00
CD1.AX income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
CD1.AX balance_sheet (annual, 2025-03-31) — Total Assets: 34156420.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Total Assets: 34156420.00
CD1.AX balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 33523406.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 33523406.00
CD1.AX balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 633014.00
CD1.AX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 633014.00
CD1.AX income_statement (annual, 2026-03-31) — +Total Revenue: -322927.00
CD1.AX balance_sheet (annual, 2026-03-31) — Accounts Payable: 115171.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 115171.00
CD1.AX cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1816686.00
CD1.AX balance_sheet (annual, 2026-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 56949566.00
CD1.AX balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1488567.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1488567.00
CD1.AX balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1488567.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1488567.00
CD1.AX cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -4751653.00
CD1.AX balance_sheet (annual, 2026-03-31) — Cash Financial: 1488567.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1488567.00
CD1.AX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -4751653.00
CD1.AX cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: 5200512.00
CD1.AX cash_flow (annual, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: -476849.00
CD1.AX cash_flow (annual, 2026-03-31) — Changes In Cash: -27990.00
CD1.AX cash_flow (annual, 2026-03-31) — Classesof Cash Payments: -513721.00
CD1.AX cash_flow (annual, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 36872.00
CD1.AX balance_sheet (annual, 2026-03-31) — Common Stock: 56949566.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Common Stock: 56949566.00
CD1.AX cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -4751653.00
CD1.AX balance_sheet (annual, 2026-03-31) — Common Stock Equity: 21808079.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 21808079.00
CD1.AX cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 5200512.00
CD1.AX cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -300129.00
CD1.AX cash_flow (annual, 2026-03-31) — End Cash Position: 1488567.00
CD1.AX cash_flow (annual, 2026-03-31) — Financing Cash Flow: -4751653.00
CD1.AX cash_flow (annual, 2026-03-31) — Free Cash Flow: -476849.00
CD1.AX income_statement (annual, 2026-03-31) — Interest Income: 36440.00
CD1.AX cash_flow (annual, 2026-03-31) — Investing Cash Flow: 5200512.00
CD1.AX balance_sheet (annual, 2026-03-31) — Investments And Advances: 21093531.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 21093531.00
CD1.AX balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 21093531.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 21093531.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Net Interest Income: 36440.00
CD1.AX balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 21808079.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 21808079.00
CD1.AX balance_sheet (annual, 2026-03-31) — Non Current Deferred Liabilities: 1136977.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1136977.00
CD1.AX balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1136977.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1136977.00
CD1.AX income_statement (annual, 2026-03-31) — Normalized Income: -6963674.00
CD1.AX income_statement (annual, 2026-03-31) — Operating Revenue: -322927.00
CD1.AX balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 36551180.00
CD1.AX income_statement (annual, 2026-03-31) — Other Non Interest Expense: 5215.00
CD1.AX income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: -5135895.00
CD1.AX balance_sheet (annual, 2026-03-31) — Other Receivables: 17397.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Other Receivables: 17397.00
CD1.AX balance_sheet (annual, 2026-03-31) — Payables: 115171.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Payables: 115171.00
CD1.AX balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 115171.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 115171.00
CD1.AX income_statement (annual, 2026-03-31) — Pretax Income: -5911571.00
CD1.AX income_statement (annual, 2026-03-31) — Professional Expense And Contract Services Expense: 447534.00
CD1.AX balance_sheet (annual, 2026-03-31) — Receivables: 17397.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Receivables: 17397.00
CD1.AX balance_sheet (annual, 2026-03-31) — Retained Earnings: -35141487.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -35141487.00
CD1.AX balance_sheet (annual, 2026-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Share Issued: 36551180.00
CD1.AX balance_sheet (annual, 2026-03-31) — Stockholders Equity: 21808079.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 21808079.00
CD1.AX balance_sheet (annual, 2026-03-31) — Tangible Book Value: 21808079.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 21808079.00
CD1.AX income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CD1.AX income_statement (annual, 2026-03-31) — Tax Provision: 1052103.00
CD1.AX income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
CD1.AX balance_sheet (annual, 2026-03-31) — Total Assets: 23060227.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Total Assets: 23060227.00
CD1.AX balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 21808079.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 21808079.00
CD1.AX balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1252148.00
CD1.AX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1252148.00
CD2.AX income_statement (annual, 2022-03-31) — +Total Revenue: -276952.00
CD2.AX balance_sheet (annual, 2022-03-31) — Accounts Receivable: 416.00
CD2.AX income_statement (annual, 2022-03-31) — Basic Average Shares: 54563008.00
CD2.AX income_statement (annual, 2022-03-31) — Basic EPS: 0.42
CD2.AX cash_flow (annual, 2022-03-31) — Beginning Cash Position: 12876566.00
CD2.AX balance_sheet (annual, 2022-03-31) — Capital Stock: 83881028.00
CD2.AX balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 11515075.00
CD2.AX balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Federal Funds Sold: 11515075.00
CD2.AX cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -37963458.00
CD2.AX balance_sheet (annual, 2022-03-31) — Cash Financial: 11515075.00
CD2.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: -41142660.00
CD2.AX cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: 40628341.00
CD2.AX cash_flow (annual, 2022-03-31) — Cash Flowsfromusedin Operating Activities Direct: -913823.00
CD2.AX cash_flow (annual, 2022-03-31) — Changes In Cash: -1428142.00
CD2.AX cash_flow (annual, 2022-03-31) — Classesof Cash Payments: -921593.00
CD2.AX cash_flow (annual, 2022-03-31) — Classesof Cash Receiptsfrom Operating Activities: 7770.00
CD2.AX balance_sheet (annual, 2022-03-31) — Common Stock: 83881028.00
CD2.AX cash_flow (annual, 2022-03-31) — Common Stock Dividend Paid: -37963458.00
CD2.AX balance_sheet (annual, 2022-03-31) — Common Stock Equity: 104653586.00
CD2.AX cash_flow (annual, 2022-03-31) — Common Stock Payments: -3170984.00
CD2.AX balance_sheet (annual, 2022-03-31) — Current Deferred Liabilities: 661428.00
CD2.AX balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 661428.00
CD2.AX income_statement (annual, 2022-03-31) — Diluted Average Shares: 54563008.00
CD2.AX income_statement (annual, 2022-03-31) — Diluted EPS: 0.42
CD2.AX cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 40628341.00
CD2.AX cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 66651.00
CD2.AX cash_flow (annual, 2022-03-31) — End Cash Position: 11515075.00
CD2.AX cash_flow (annual, 2022-03-31) — Financing Cash Flow: -41142660.00
CD2.AX cash_flow (annual, 2022-03-31) — Free Cash Flow: -913823.00
CD2.AX balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 416.00
CD2.AX income_statement (annual, 2022-03-31) — Interest Income: 7834.00
CD2.AX cash_flow (annual, 2022-03-31) — Investing Cash Flow: 40628341.00
CD2.AX balance_sheet (annual, 2022-03-31) — Investments And Advances: 100526700.00
CD2.AX balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 100526700.00
CD2.AX cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: -3170984.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Net Interest Income: 7834.00
CD2.AX cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -8218.00
CD2.AX balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 104653586.00
CD2.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 6565562.00
CD2.AX balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 6565562.00
CD2.AX income_statement (annual, 2022-03-31) — Normalized Income: 22652782.00
CD2.AX income_statement (annual, 2022-03-31) — Operating Revenue: -276952.00
CD2.AX balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 53170378.00
CD2.AX income_statement (annual, 2022-03-31) — Other Non Interest Expense: 4829.00
CD2.AX income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 26583490.00
CD2.AX balance_sheet (annual, 2022-03-31) — Other Payable: 188064.00
CD2.AX balance_sheet (annual, 2022-03-31) — Other Receivables: 26865.00
CD2.AX balance_sheet (annual, 2022-03-31) — Payables: 188064.00
CD2.AX balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 188064.00
CD2.AX income_statement (annual, 2022-03-31) — Pretax Income: 25551477.00
CD2.AX income_statement (annual, 2022-03-31) — Professional Expense And Contract Services Expense: 750232.00
CD2.AX balance_sheet (annual, 2022-03-31) — Receivables: 27281.00
CD2.AX cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: -3170984.00
CD2.AX balance_sheet (annual, 2022-03-31) — Retained Earnings: 20772558.00
CD2.AX balance_sheet (annual, 2022-03-31) — Share Issued: 53170378.00
CD2.AX balance_sheet (annual, 2022-03-31) — Stockholders Equity: 104653586.00
CD2.AX balance_sheet (annual, 2022-03-31) — Tangible Book Value: 104653586.00
CD2.AX income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
CD2.AX income_statement (annual, 2022-03-31) — Tax Provision: 2898695.00
CD2.AX income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.11
CD2.AX balance_sheet (annual, 2022-03-31) — Total Assets: 112069056.00
CD2.AX balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 104653586.00
CD2.AX balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 7415054.00
CD2.AX income_statement (annual, 2023-03-31) — +Total Revenue: 358833.00
CD2.AX balance_sheet (annual, 2023-03-31) — Accounts Payable: 177433.00
CD2.AX balance_sheet (annual, 2023-03-31) — Accounts Receivable: 9316.00
CD2.AX income_statement (annual, 2023-03-31) — Basic Average Shares: 52558879.00
CD2.AX income_statement (annual, 2023-03-31) — Basic EPS: -0.05
CD2.AX cash_flow (annual, 2023-03-31) — Beginning Cash Position: 11515075.00
CD2.AX balance_sheet (annual, 2023-03-31) — Capital Stock: 82891568.00
CD2.AX balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 10328531.00
CD2.AX balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 10328531.00
CD2.AX cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -17842889.00
CD2.AX balance_sheet (annual, 2023-03-31) — Cash Financial: 10328531.00
CD2.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: -18868595.00
CD2.AX cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: 17972204.00
CD2.AX cash_flow (annual, 2023-03-31) — Cash Flowsfromusedin Operating Activities Direct: -1441243.00
CD2.AX cash_flow (annual, 2023-03-31) — Changes In Cash: -2337634.00
CD2.AX cash_flow (annual, 2023-03-31) — Classesof Cash Payments: -1570152.00
CD2.AX cash_flow (annual, 2023-03-31) — Classesof Cash Receiptsfrom Operating Activities: 128909.00
CD2.AX balance_sheet (annual, 2023-03-31) — Common Stock: 82891568.00
CD2.AX cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -17842889.00
CD2.AX balance_sheet (annual, 2023-03-31) — Common Stock Equity: 83379498.00
CD2.AX cash_flow (annual, 2023-03-31) — Common Stock Payments: -1025706.00
CD2.AX balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 1303691.00
CD2.AX balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 1303691.00
CD2.AX income_statement (annual, 2023-03-31) — Diluted Average Shares: 52558879.00
CD2.AX income_statement (annual, 2023-03-31) — Diluted EPS: -0.05
CD2.AX cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 17972204.00
CD2.AX cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 1151090.00
CD2.AX cash_flow (annual, 2023-03-31) — End Cash Position: 10328531.00
CD2.AX cash_flow (annual, 2023-03-31) — Financing Cash Flow: -18868595.00
CD2.AX cash_flow (annual, 2023-03-31) — Free Cash Flow: -1441243.00
CD2.AX balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9316.00
CD2.AX cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 382366.00
CD2.AX income_statement (annual, 2023-03-31) — Interest Income: 137809.00
CD2.AX cash_flow (annual, 2023-03-31) — Investing Cash Flow: 17972204.00
CD2.AX balance_sheet (annual, 2023-03-31) — Investments And Advances: 80567573.00
CD2.AX balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 80567573.00
CD2.AX cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -1025706.00
CD2.AX income_statement (annual, 2023-03-31) — Net Income: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -2441739.00
CD2.AX income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -2441739.00